+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Left Atrial Appendage Closure Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • September 2021
  • Region: Global
  • TechNavio
  • ID: 5509401
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

This publisher has monitored the left atrial appendage closure market and according to this report it is poised to grow by $1.67 Billion during 2021-2025, progressing at a CAGR of almost 18% during the forecast period. The report the left atrial appendage closure market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing incidences of atrial fibrillation and growing product approvals fueling the market growth.

The left atrial appendage closure market analysis includes the product segment and geographic landscape.

The left atrial appendage closure market is segmented as below:


By Product


  • Epicardial LAA closure device
  • Endocardial LAA closure device

By Geographical Landscape


  • North America
  • Europe
  • Asia

This study identifies the potential long-term cost-effectiveness associated with the use of LAA closure devices as one of the prime reasons driving the left atrial appendage closure market growth during the next few years.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The report left atrial appendage closure market covers the following areas:


  • Left atrial appendage closure market sizing
  • Left atrial appendage closure market forecast

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading left atrial appendage closure market vendors that include Abbott Laboratories, Append Medical, AtriCure Inc., Boston Scientific Corp., Cardia Inc., Johnson and Johnson Inc., Lepu Medical Technology (Beijing) Co. Ltd., Lifetech Scientific (Shenzhen) Co. Ltd., Occlutech International AB, and SentreHEART Inc. Also, the left atrial appendage closure market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
  • Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Epicardial LAA closure device - Market size and forecast 2020-2025
  • Endocardial LAA closure device - Market size and forecast 2020-2025

Market opportunity by ProductCustomer landscapeCustomer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Append Medical
  • AtriCure Inc.
  • Boston Scientific Corp.
  • Cardia Inc.
  • Johnson and Johnson Inc.
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Lifetech Scientific (Shenzhen) Co. Ltd.
  • Occlutech International AB
  • SentreHEART Inc.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)

Five Forces Analysis
2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Epicardial LAA closure device - Market size and forecast 2020-2025 ($ million)
  • Epicardial LAA closure device - Year-over-year growth 2020-2025 (%)
  • Endocardial LAA closure device - Market size and forecast 2020-2025 ($ million)
  • Endocardial LAA closure device - Year-over-year growth 2020-2025 (%)

Market opportunity by Product
Customer landscape
  • Market share By Geographical Landscape 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ million)
  • Impact of drivers and challenges

Vendor Landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Key customers
  • Abbott Laboratories - Segment focus
  • Append Medical - Overview
  • Append Medical - Product and service
  • Append Medical - Key offerings
  • Append Medical - Key customers
  • Append Medical - Segment focus
  • AtriCure Inc. - Overview
  • AtriCure Inc. - Business segments
  • AtriCure Inc. - Key offerings
  • AtriCure Inc. - Key customers
  • AtriCure Inc. - Segment focus
  • Boston Scientific Corp. - Overview
  • Boston Scientific Corp. - Business segments
  • Boston Scientific Corp. - Key offerings
  • Boston Scientific Corp. - Key customers
  • Boston Scientific Corp. - Segment focus
  • Cardia Inc. - Overview
  • Cardia Inc. - Product and service
  • Cardia Inc. - Key offerings
  • Cardia Inc. - Key customers
  • Cardia Inc. - Segment focus
  • Johnson and Johnson Inc. - Overview
  • Johnson and Johnson Inc. - Business segments
  • Johnson and Johnson Inc. - Key offerings
  • Johnson and Johnson Inc. - Key customers
  • Johnson and Johnson Inc. - Segment focus
  • Lepu Medical Technology (Beijing) Co. Ltd. - Overview
  • Lepu Medical Technology (Beijing) Co. Ltd. - Product and service
  • Lepu Medical Technology (Beijing) Co. Ltd. - Key offerings
  • Lepu Medical Technology (Beijing) Co. Ltd. - Key customers
  • Lepu Medical Technology (Beijing) Co. Ltd. - Segment focus
  • Lifetech Scientific (Shenzhen) Co. Ltd. - Overview
  • Lifetech Scientific (Shenzhen) Co. Ltd. - Business segments
  • Lifetech Scientific (Shenzhen) Co. Ltd. - Key offerings
  • Lifetech Scientific (Shenzhen) Co. Ltd. - Key customers
  • Lifetech Scientific (Shenzhen) Co. Ltd. - Segment focus
  • Occlutech International AB - Overview
  • Occlutech International AB - Product and service
  • Occlutech International AB - Key offerings
  • Occlutech International AB - Key customers
  • Occlutech International AB - Segment focus
  • SentreHEART Inc. - Overview
  • SentreHEART Inc. - Product and service
  • SentreHEART Inc. - Key offerings
  • SentreHEART Inc. - Key customers
  • SentreHEART Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher has identified the following companies as the key players in the global left atrial appendage closure market: Abbott Laboratories, Append Medical, AtriCure Inc., Boston Scientific Corp., Cardia Inc., Johnson and Johnson Inc., Lepu Medical Technology (Beijing) Co. Ltd., Lifetech Scientific (Shenzhen) Co. Ltd., Occlutech International AB, and SentreHEART Inc.

Commenting on the report, an analyst from the publisher said 'The latest trend gaining momentum in the market is potential long-term cost-effectiveness associated with the use of LAA closure devices.'

According to the report, one of the major drivers for this market is the increasing incidences of atrial fibrillation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Append Medical
  • AtriCure Inc.
  • Boston Scientific Corp.
  • Cardia Inc.
  • Johnson and Johnson Inc.
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Lifetech Scientific (Shenzhen) Co. Ltd.
  • Occlutech International AB
  • Sentre